
Sign up to save your podcasts
Or


Great trial this week looking at brepocitinib in dermatomyositis. Looks like a winner, expect it will be approved. Where it fits in our approach to IIM is an open question, but nice to have another option.
Study: https://www.nejm.org/doi/10.1056/NEJMoa2503531
JC Companion: https://autoimmunedevreport.substack.com/
By Michael Putman4.9
114114 ratings
Great trial this week looking at brepocitinib in dermatomyositis. Looks like a winner, expect it will be approved. Where it fits in our approach to IIM is an open question, but nice to have another option.
Study: https://www.nejm.org/doi/10.1056/NEJMoa2503531
JC Companion: https://autoimmunedevreport.substack.com/

506 Listeners

299 Listeners

124 Listeners

3,360 Listeners

1,152 Listeners

120 Listeners

197 Listeners

517 Listeners

68 Listeners

4 Listeners

373 Listeners

182 Listeners

188 Listeners

17 Listeners

6 Listeners